Encompass Health Corp’s filing revealed that its Chief Accounting Officer Price Andrew L unloaded Company’s shares for reported $0.5 million on Feb 13 ’25. In the deal valued at $98.29 per share,5,042 shares were sold. As a result of this transaction, Price Andrew L now holds 69,164 shares worth roughly $6.75 million.
Then, COLTHARP DOUGLAS E sold 12,260 shares, generating $1,058,474 in total proceeds. Upon selling the shares at $86.34, the EVP & Chief Financial Officer now owns 136,227 shares.
Before that, Douglas Coltharp bought 12,260 shares. Encompass Health Corp shares valued at $1,058,520 were divested by the Officer at a price of $86.34 per share.
KeyBanc Capital Markets initiated its Encompass Health Corp [EHC] rating to an Overweight in a research note published on October 11, 2024; the price target was $115. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Barclays began covering EHC with “an Overweight” recommendation on March 06, 2024. Barclays started covering the stock on March 14, 2023. It rated EHC as “an Equal weight”.
Price Performance Review of EHC
On Tuesday, Encompass Health Corp [NYSE:EHC] saw its stock fall -0.11% to $97.64. Over the last five days, the stock has gained 0.67%. Encompass Health Corp shares have risen nearly 5.73% since the year began. Nevertheless, the stocks have risen 30.00% over the past one year. While a 52-week high of $104.55 was reached on 02/07/25, a 52-week low of $74.45 was recorded on 01/03/25. SMA at 50 days reached $97.33, while 200 days put it at $93.90.
Levels Of Support And Resistance For EHC Stock
The 24-hour chart illustrates a support level at 96.63, which if violated will result in even more drops to 95.63. On the upside, there is a resistance level at 98.34. A further resistance level may holdings at 99.05. The Relative Strength Index (RSI) on the 14-day chart is 48.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.33%. Stochastics %K at 52.74% indicates the stock is a holding.
How much short interest is there in Encompass Health Corp?
A steep rise in short interest was recorded in Encompass Health Corp stocks on 2025-02-28, growing by 0.62 million shares to a total of 2.11 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 1.49 million shares. There was a rise of 29.42%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 24, 2021 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $98 price target.
